News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Aakash Desai: Rybrevant + Lazcluze to show clinically meaningful improvement in OS vs osimertinib
Aakash Desai/LinkedIn
Jan 9, 2025, 16:29

Aakash Desai: Rybrevant + Lazcluze to show clinically meaningful improvement in OS vs osimertinib

Aakash Desai, Assistant Professor at UAB O’Neal Comprehensive Cancer Center, shared on X:

“MARIPOSA Johnson and Johnson announces Positive OS results in 1L EGFR

Amivantamab + lazertinib vs. osimertinib:
Statistically significant improvement in OS (press release states >1 yr survival benefit)
Await complete data and presentation.”

Aakash Desai: Rybrevant + Lazcluze to show clinically meaningful improvement in OS vs osimertinib

 

Aakash Desai cancer EGFR Lung cancer OncoDaily Oncology
Special Coverage
Blog
Apr 19, 2025, 06:03
Lars Dyrskjøt: Circulating tumour DNA and circulating tumour cells in bladder cancer
Blog
Apr 19, 2025, 05:31
Swapnil Patel: Looking forward to an excellent academic feast on PSM this summer
Cancer Types
Apr 19, 2025, 03:00
Small Cell Lung Cancer: Symptoms, Causes, Types, Diagnosis and Treatment
Opinion
Apr 19, 2025, 01:47
Essential Medicines for Children with Cancer: From Access to Action – A Powerful OncoDaily Virtual Forum
Opinion
Apr 19, 2025, 01:45
Dr. Don Dizon and Dr. Nathan Pennell Reflect on the Evolution of the ASCO Educational Book
Blog
Apr 19, 2025, 01:45
Shray Saheba: I had the exciting opportunity to present my research at the National Research Conference hosted by Brown University
Blog
Apr 19, 2025, 01:42
Highlights from Brown University's Inaugural National Undergraduate Research Conference
Blog
Apr 19, 2025, 01:22
National Cancer Control Plans ensures better prevention, early diagnosis and treatment for all - UICC
Blog
Apr 19, 2025, 01:19
Milos Grujic: Patient-Reported Outcomes with Talazoparib plus Enzalutamide
Science
Apr 19, 2025, 01:13
Filipe Nadir Caparica Santos: The potential of internationally trained physicians
Blog
Apr 19, 2025, 01:05
Join ESTRO 2025 for a series of debate sessions on radiation oncology
Blog
Apr 19, 2025, 01:00
Norman Ng: Joanne Chiu discusses the remarkable advancements in cancer treatment and the potential for long-term survival